title: TrkA pathway activation induced by amyloid-beta (Abeta).
abstract: Amyloid-beta (Abeta), a cytotoxic fragment of Amyloid Precursor Protein (APP), has been implicated in the etiopathogenesis of Alzheimer's disease (AD). Since several neurotrophins signalling pathways may be activated in response to toxic insults, we investigated whether a similar response is triggered also by Abeta. After Abeta (25-35) peptide administration to cultured rat hippocampal neurons, the nerve growth factor (NGF) and its receptor (TrkA) mRNA expression is up-regulated. Moreover, we observe an increased cellular TrkA expression (4.5 fold) and NGF release in the culture medium (5-fold). Concomitantly, TrkA, Akt and glycogen synthase kinase 3beta (Gsk3beta) phosphorylation significantly increase. Interestingly, when cells were treated with Abeta (25-35) in the presence of blocking antibody against NGF, only a partial TrkA activation (2-fold) was observed. These results have been confirmed by using pathophysiological Abeta (1-42) oligomers. Our data provide the evidence that Abeta induces the TrkA pathway activation directly by itself and indirectly promoting NGF secretion.
authors.affiliation: Department of Experimental Medicine, University of Milano-Bicocca, Monza (MI), Italy. alessandra.bulbarelli@unimib.it
authors.forename: Alessandra
authors.initials: A
authors.lastname: Bulbarelli
authors.forename: Elena
authors.initials: E
authors.lastname: Lonati
authors.forename: Emanuela
authors.initials: E
authors.lastname: Cazzaniga
authors.forename: Francesca
authors.initials: F
authors.lastname: Re
authors.forename: Silvia
authors.initials: S
authors.lastname: Sesana
authors.forename: Donatella
authors.initials: D
authors.lastname: Barisani
authors.forename: Giulio
authors.initials: G
authors.lastname: Sancini
authors.forename: Tatsuro
authors.initials: T
authors.lastname: Mutoh
authors.forename: Massimo
authors.initials: M
authors.lastname: Masserini
mesh_terms: D016229:Amyloid beta-Peptides / Q000494:pharmacology*; D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics / Q000378:metabolism; D020169:Caspases / Q000378:metabolism; D002478:Cells, Cultured; D004789:Enzyme Activation; D006624:Hippocampus / Q000166:cytology; D020932:Nerve Growth Factor / Q000235:genetics / Q000378:metabolism; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D010446:Peptide Fragments / Q000494:pharmacology*; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics / Q000378:metabolism; D051381:Rats; D020917:Receptor, trkA / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology
chemical_list: D016229:Amyloid beta-Peptides; D019208:Brain-Derived Neurotrophic Factor; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42); C074636:amyloid beta-protein (25-35); D020932:Nerve Growth Factor; D020917:Receptor, trkA; D051057:Proto-Oncogene Proteins c-akt; D020169:Caspases